ARTV
Artiva Biotherapeutics, Inc. Common Stock
ARTV
ARTV
57 hedge funds and large institutions have $213M invested in Artiva Biotherapeutics, Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 18 increasing their positions, 6 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
57
Holders Change
+9
Holders Change %
+18.75%
% of All Funds
0.76%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
10
Increased
18
Reduced
6
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BlackRock
New York
|
+$2.1M |
| 2 |
State Street
Boston,
Massachusetts
|
+$788K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$290K |
| 4 |
JPMorgan Chase & Co
New York
|
+$271K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$261K |
Top Sellers
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$70.6K |
| 2 |
SO
STRS Ohio
Columbus,
Ohio
|
-$40.2K |
| 3 |
Morgan Stanley
New York
|
-$26.9K |
| 4 |
RhumbLine Advisers
Boston,
Massachusetts
|
-$19.7K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$9.5K |
